Marc Debled

机构：Institut Bergonié

发表论文 251 篇 · 总被引 8360 次 · h-index 43

代表论文

• Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial (2025 · The Lancet · 被引 14)
• Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study (2023 · Cancers · 被引 14)
• Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial (2024 · EBioMedicine · 被引 12)
• Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data (2023 · The Breast · 被引 12)
• Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation (2023 · British Journal of Cancer · 被引 7)
• Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in NATALEE: Analysis across menopausal status and age. (2025 · Journal of Clinical Oncology · 被引 4)